Search Results for: stem cells for ms

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports

Neurons-created-from-ciNSC

What is direct reprogramming ? There’s some big, positive news on this stem cell front today. All chemical direct reprogramming Two new innovative papers both by teams led by Sheng Ding of Gladstone Institutes with UCSF report all-chemical direct reprogramming of human somatic cells. Ding’s team took skin cells and by exposing them to cocktails of […]

Big stem cell news: dynamic duo of all-chemical direct reprogramming reports Read More »

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells

Vatican-stem-cell-meeting

What is a Vatican Stem Cell Meeting like? Over the years, the Vatican has expressed interest and even invested money in the adult stem cell field. Not surprisingly, they’ve also been critical of embryonic stem cell research. Interestingly their own stem cell meetings have at times stimulated heated debate for various reasons and one was even cancelled with

Perspectives on Vatican Stem Cell Meeting: CIRM, Embryonic & Adult Stem Cells Read More »

Stem cell myths: they are homologous to everything

spackle-stem-cells-e1472152006313

Some stem cell clinics sometimes use questionable ideas to bypass FDA regulations and I’d go far as to say some of these are outright stem cell myths. One such argument that seems like a myth in my opinion relates to the idea of “homologous use”, which is one of the hottest issues in stem cells in the clinical arena right

Stem cell myths: they are homologous to everything Read More »

New Mitalipov paper on stem cell mitochondria: challenge for IPS cell field?

Mitalipov-mitochondrial-mutations

A new paper from Shoukhrat Mitalipov’s lab on stem cell mitochondria points to a pattern whereby induced pluripotent stem (IPS) cells tend to have more problems if they are from older patients. New Mitalipov paper What does this paper mean for the stem cell field and could it impact more specifically the clinical applications of IPS

New Mitalipov paper on stem cell mitochondria: challenge for IPS cell field? Read More »

Review of Centeno MSC safety paper: without controls, conclusions muted

Centeno-Table-3

The number of people around the world being injected with stem cells every day has never been higher and the heterogeneous group of medical providers doing these procedures is also at or near its highest level ever. The cells used are also highly variable as are the procedures themselves, but most of these cells fall under the

Review of Centeno MSC safety paper: without controls, conclusions muted Read More »

Stem cell clinic Nervana new ad claims no side effects & FDA OK

Nervana-ad-march-28

Stem cell clinics like Nervana are spreading like wild-fire across the U.S. A few months back the Sacramento area got a new stem cell clinic selling amniotic stem cell therapies for a variety of ills including most prominently arthritis and pain. This clinic is called Nervana Stem Cell Center. I first noticed it via a

Stem cell clinic Nervana new ad claims no side effects & FDA OK Read More »

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA

BPC-report-stem-cels

There is considerable interest in FDA regulatory reform here in the U.S. for stem cell therapies. The goal is to get new treatments to patients faster, but is there a way to do that without sacrificing proven safety and efficacy? You need convincing data on both safety and efficacy or speed becomes dangerous. Bipartisan Policy Center

Cons Outweigh Potential Pros to BPC Plan on Stem Cells & FDA Read More »

New Stem Cell Clinic Trial for Alzheimer’s: Perspectives & Questions

Test-for-Alzheimers-Disease1

A team at the University of Miami has launched a claimed first of its kind stem cell clinic trial for Alzheimer’s Disease (AD). The trial seems somewhat unique in using mesenchymal stem cells (MSC) for AD and is being run with biotech Longeveron. You can read more on the actual clinic trial including all the

New Stem Cell Clinic Trial for Alzheimer’s: Perspectives & Questions Read More »